Kontakt 2005, 7(1-2):138-140 | DOI: 10.32725/kont.2005.027

Ebola virus and bioterrorismBiomedicine

Zuzana Skalická
Jihočeská univerzita v Českých Budějovicích, Zdravotně sociální fakulta

Viruses causing hemorrhagic fever are potential agents for the biological war, since they can be transferred with the help of an aerosol and they exert high morbidity and mortality after the origination of infection and capability of mass replication in cell cultures. In the work, the Ebola virus and hemorrhagic fever caused by this virus are described. The Ebola virus is one of the most fatal viruses known to the man.

Keywords: Ebola virus; hemorrhagic fever; bioterrorism

Published: June 29, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Skalická Z. Ebola virus and bioterrorism. Kontakt. 2005;7(1-2):138-140. doi: 10.32725/kont.2005.027.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Baron, R.C., McCormick, J.B., Zubeir, O.A. 1983: Ebola virus disease in southern Sudan: Hospital dissemination and intrafamilial spread. Bull. World Health Organ. 61: 997-1003. Go to PubMed...
    2. Bray, M. 2003: Defense against filoviruses used as biological weapons. Antiviral Res. Jan;57 (1-2):53-60. Go to original source... Go to PubMed...
    3. Bronze, M.S., Greenfield, R.A. 2003: Therapeutic options for diseases due to potential viral agents of bioterrorism. Curr Opin Investig Drugs. 2003 Feb; 4(2):172-8. Go to PubMed...
    4. Feldmann, H., Klenk, H.D., Sanchez, A. 1993: Molecular biology and evolution of filoviruses. Arch Virol Suppl. 7:81-100. Go to original source... Go to PubMed...
    5. Feldmann, H., Wahl-Jensen, V., Jones, S.M., Stroher, U. 2004: Ebola virus ecology a continuing mystery. Trends Microbiol. 12:433-437. Go to original source... Go to PubMed...
    6. Gibbs, W.W. 2004: An uncertain defense. How do you test that a human Ebola vaccine works? You don't. Sci Am. 291:20, 24. Go to original source...
    7. Han, S.Z., Alfano, M.C., Psoter, W.J., Rekow, E.D. 2003: Bioterrorism and catastrophe response - A quick-reference guide to resources. Journal of the American dental association 134 (6): 745-752 JUN Go to original source... Go to PubMed...
    8. Jaax, N.K., Davis, K.J., Geisbert, T.J., Vogel, P., Jaax, G.P., Topper, M., Jahrling, P.B. 1996: Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med. 120:140-155.
    9. Lamunu, M., Lutwama, J.J., Kamugisha, J., Opio, A., Nambooze, J., Ndayimirije, N., Okware, S. 2004: Containing a haemorrhagic fever epidemic, the Ebola experience in Uganda (October 2000-January 2001). Int J Infect Dis. Jan;8(1):27-37. Go to original source... Go to PubMed...
    10. Lowenstein, R. 2004: Deadly viral syndrome mimics. Emerg Med Clin North Am. 22:1051-1065 Lucht, A., Grunow, R., Otterbein, C., Moller, P., Feldmann, H., Becker, S. 2004: Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus. Med Microbiol Immunol (Berl).193:181-187. Go to original source...
    11. Macela, A. a kol. 2002: Vysoce riziková biologická agens. Azin, Praha.
    12. Měrka, J. 2001: Ebola, málo známá a příliš exotická infekce? Zprav Voj. Farm. 11: 8-9.
    13. Van Cakenberghe, V., De Vree, F., Leirs, H. 1999: On a collection of bats (Chiroptera) from Kikwit, Democratic Republic of the Congo MAMMALIA 63 (3): 291-322 Go to original source...
    14. Polesky, A., Bhatia, G. 2003: Ebola hemorrhagic fever in the era of bioterrorism. Semin Respir Infect. 18:206-215. Go to PubMed...
    15. Sureau, P.H. 1989: Firsthand clinical observations of hemorrhagic manifestations in Ebola hemorrhagic fever in Zaire. Rev Infect Dis. May-Jun;11 Suppl 4:S790-3. Go to original source... Go to PubMed...
    16. Towner, J.S., Rollin, P.E., Bausch, D.G., Sanchez, A., Crary, S.M., Vincent, M., Lee, W.F., Spiripoulou, C.F., Ksiazek, T.G., Lukwiya, M., Kaducu, F., Downing, R., Nichol, S.T. 2004: Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 78:4330-4341. Go to original source... Go to PubMed...
    17. Yang, Z.Y., Duckers, H.J., Sullivan, N.J., Sanchez, A., Nabel, E.G., Nabel, G.J. 2000: Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med. 6:886-889. Go to original source... Go to PubMed...
    18. Zabavichene, N.M., Chepurnov, A.A. 2004: Dynamics of complement hemolytic activity in experimental Ebola infection (Article in Russian) Vopr Virusol. 49:21-25. Go to PubMed...

    Return to the content